Covered recipient · General Payments record
JOHN THOMAS HIBLER
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,786.08
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $404.81 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $257.42 | 12 |
| Amgen Inc. | $50.90 | 2 |
| GENZYME CORPORATION | $46.43 | 2 |
| Regeneron Healthcare Solutions, Inc. | $33.32 | 1 |
| LEO Pharma Inc. | $16.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $100.71 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915179 | CMS |
| ABBVIE INC. | $9.29 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915181 | CMS |
| ABBVIE INC. | $4.11 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915183 | CMS |
| ABBVIE INC. | $18.74 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915185 | CMS |
| ABBVIE INC. | $24.72 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915187 | CMS |
| ABBVIE INC. | $20.55 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915189 | CMS |
| ABBVIE INC. | $4.15 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915191 | CMS |
| ABBVIE INC. | $22.13 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915193 | CMS |
| ABBVIE INC. | $18.87 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915195 | CMS |
| ABBVIE INC. | $10.29 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915197 | CMS |
| ABBVIE INC. | $10.00 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915199 | CMS |
| ABBVIE INC. | $13.86 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103915201 | CMS |
| Amgen Inc. | $23.17 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117277172 | CMS |
| Amgen Inc. | $27.73 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117277174 | CMS |
| GENZYME CORPORATION | $20.59 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139943985 | CMS |
| GENZYME CORPORATION | $25.84 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139944073 | CMS |
| LEO Pharma Inc. | $16.74 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152634353 | CMS |
| Regeneron Healthcare Solutions, Inc. | $33.32 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114069001 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.